Glucosamine for joint health: C → C
Merged additional source by Claude (gold-standard provenance sweep): a distinct, independently-verified paper ("Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis.", PMID 38581640) reporting the same intervention×outcome was found instead of being discarded as a duplicate — same claim, one more piece of real evidence.
What triggered this change
Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis.. Read: Substrate breakdown · PubMed.
What we said before vs now
What this does not change
- Interaction profile for Glucosamine — unchanged unless there is a separate severity change.
- Dose guidance — unchanged unless the new evidence altered the studied dose range.
- Safety recommendations — unchanged unless a safety event is recorded separately.
Reviewer & methodology
Reviewed and signed by Substrate editorial (Independent research collective) on . Methodology v1.
See also
Cite this page
Reuse under CC-BY 4.0 with attribution to evidencebased.info.
Plain-text citation
Substrate. Glucosamine for joint health: C → C. https://evidencebased.info/changes/2026-07-16-glucosamine-joints-c-to-c. Updated 2026-07-16.
BibTeX
@misc{substrate_lucosaminejointsctoc,
author = {Substrate editorial},
title = {Glucosamine for joint health: C → C},
year = {2026},
url = {https://evidencebased.info/changes/2026-07-16-glucosamine-joints-c-to-c},
note = {evidencebased.info}
}